(c) 2024 PillSync.com

rosuvastatin calcium 10 mg

1 INDICATIONS AND USAGE Rosuvastatin tablets are indicated: Rosuvastatin tablets are indicated: Rosuvastatin tablets are an HMG Co-A reductase inhibitor (statin) indicated: ( 1 ) • To reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease based on age, high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, and at least one additional CV risk factor. • As an adjunct to diet to: o reduce LDL-C in adults with primary hyperlipidemia. o reduce LDL-C and slow the progression of atherosclerosis in adults. o reduce LDL-C in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH). • As an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH). • As an adjunct to diet for the treatment of adults with: o primary dysbetalipoproteinemia. o Hypertriglyceridemia.

glenmark pharmaceutials inc., usa


6 months ago ROUND BROWN G D rosuvastatin calcium 10 mg

ROUND BROWN G D

6 months ago ROUND BROWN G D rosuvastatin calcium 10 mg

G D ROUND BROWN

16 HOW SUPPLIED/STORAGE AND HANDLING Rosuvastatin Tablets, USP are supplied as: Strength How Supplied NDC Tablet Description 5 mg Bottles of 30 with child-resistant closure 68462-261-30 pink colored, film-coated, circular tablets debossed with “G” on one side and “C” on the other side. Bottles of 50 with child-resistant closure 68462-261-50 Bottles of 90 with child-resistant closure 68462-261-90 Bottles of 100 with child-resistant closure 68462-261-01 Bottles of 1,000 68462-261-10 Carton unit-dose pack of 100 (10x10) 68462-261-11 10 mg Bottles of 30 with child-resistant closure 68462-262-30 pink colored, film-coated, circular tablets debossed with “G” on one side and “D” on the other side. Bottles of 50 with child-resistant closure 68462-262-50 Bottles of 90 with child-resistant closure 68462-262-90 Bottles of 100 with child-resistant closure 68462-262-01 Bottles of 1,000 68462-262-10 Carton unit-dose pack of 100 (10x10) 68462-262-11 20 mg Bottles of 30 with child-resistant closure 68462-263-30 pink colored, film-coated, circular tablets debossed with “G” on one side and “O” on the other side Bottles of 50 with child-resistant closure 68462-263-50 Bottles of 90 with child-resistant closure 68462-263-90 Bottles of 100 with child-resistant closure 68462-263-01 Bottles of 1,000 68462-263-10 Carton unit-dose pack of 100 (10x10) 68462-263-11 40 mg Bottles of 30 with child-resistant closure 68462-264-30 pink colored, film-coated, oval shaped tablets debossed with “G264” on one side and “40” on the other side. Bottles of 50 with child-resistant closure 68462-264-50 Bottles of 90 with child-resistant closure 68462-264-90 Bottles of 100 with child-resistant closure 68462-264-01 Bottles of 500 68462-264-05 Bottles of 1,000 68462-264-10 Storage Store at controlled room temperature, 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Protect from moisture.


More pills like ROUND G D

Related Pills

rosuvastatin calcium 10 mg

glenmark pharmaceutials inc., usa

rosuvastatin calcium 5 mg

glenmark pharmaceutials inc., usa

Rosuvastatin calcium 20 mg

Glenmark Pharmaceutials Inc., USA

Rosuvastatin calcium 40 mg

glenmark pharmaceutials inc., usa

rosuvastatin calcium 5 mg

glenmark pharmaceutials inc., usa

rosuvastatin calcium 10 mg

glenmark pharmaceutials inc., usa

Rosuvastatin calcium 20 mg

glenmark pharmaceutials inc., usa

triamterene 50 mg

prasco laboratories

triamterene 100 mg

prasco laboratories












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site